Abstract
Chemical modification of proteins with monomethoxypolyethylene glycol (mPEG) will reduce the immunogenicity of proteins. In the present study, we evaluated the effect of mPEG modification on the capacity of hen egg-white lysozyme (HEL) to stimulate T cells. Lymph node cells (LNCs) from mice immunized with HEL or with mPEG-HEL conjugate were cultured with these antigens, then we measured the proliferation and IL-2 production. mPEG-modification lowered the T cell activating capacity of HEL, both in vitro and in vivo. Neither toxicity, nor antigen non-specific immunosuppressive capacity was observed with mPEG-HEL and unconjugated mPEG. Suppressor cells were unlikely to be generated in the mPEG-HEL-primed LNCs. We next examined the behavior of mPEG-HEL during antigen processing. The capacity of HEL and mPEG-HEL to be incorporated by live cells was much the same. However, the susceptibility to various proteases, including endosomal/lysosomal enzymes, was significantly decreased by mPEG modification. The increased resistance of mPEG-HEL to proteolytic degradation implied that the conjugate was poorly presented to T cells. This may be an important factor related to the low immunogenicity of mPEG modified proteins.
References
Jan 1, 1978·International Archives of Allergy and Applied Immunology·W Y Lee, A H Sehon
Jun 16, 1977·Nature·W Y Lee, A H Sehon
Mar 1, 1991·The Journal of Experimental Medicine·G GammonE E Sercarz
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·L AdoriniE Appella
Dec 1, 1988·The Journal of Experimental Medicine·L AdoriniZ A Nagy
Jan 1, 1989·Bone·T TsuboyamaT Takeda
May 1, 1987·Immunology Letters·I WilkinsonA H Sehon
Aug 15, 1987·Analytical Biochemistry·C J JacksonA H Sehon
Mar 5, 1987·The New England Journal of Medicine·M S HershfieldA L Kobayashi
Feb 1, 1987·Cellular Immunology·V Holford-StrevensA H Sehon
Jan 1, 1985·International Archives of Allergy and Applied Immunology·K KawamuraS Kishimoto
May 1, 1971·The Journal of Clinical Investigation·R G PetersonM S Mitchell
Mar 1, 1966·Analytical Biochemistry·A F Habeeb
Nov 1, 1973·Cancer·D P Byar
Dec 16, 1983·Journal of Immunological Methods·T Mosmann
Nov 1, 1993·The Journal of Experimental Medicine·T M FoyR J Noelle
Oct 1, 1994·Protein Engineering·Y MaedaT Imoto
Oct 1, 1994·Journal of Biochemistry·H YamadaT Imoto
Nov 8, 1994·Biochemistry·H TomizawaT Imoto
Sep 1, 1994·European Journal of Immunology·J M van Noort, M J Jacobs
Dec 1, 1993·Seminars in Immunology·A K AbbasS A Bogen
Citations
Oct 29, 2003·Pulmonary Pharmacology & Therapeutics·J-P LavoieJ G Martin
Nov 28, 2001·Immunology·T SoT Imoto
Oct 25, 2002·Human Gene Therapy·Maria A CroyleJames M Wilson
Apr 20, 2001·Journal of Virology·M A CroyleJ M Wilson
Jun 26, 2003·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Taiji Imoto
Jul 22, 2010·Pharmaceutical Biology·Débora da Silva Freitas, José Abrahão-Neto
Oct 30, 2007·Trends in Immunology·Anne S De Groot, David W Scott
Jul 5, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Julia LanciottiCatherine O'Riordan
Sep 2, 1999·Protein Engineering·T SoT Imoto
Oct 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·Y TsujihataT Imoto
Jan 24, 1998·The Journal of Biological Chemistry·T SoT Imoto
Jun 9, 1998·Immunology·H O ItoT Imoto
Sep 8, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Takatoshi OhkuriTadashi Ueda